Copyright
©The Author(s) 2016.
World J Gastrointest Oncol. Apr 15, 2016; 8(4): 351-357
Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.351
Published online Apr 15, 2016. doi: 10.4251/wjgo.v8.i4.351
Figure 1 Mechanisms of colorectal cancer and colitis-associated cancer development.
APC: Adenomatous polyposis coli; TGFβ: Transforming growth factor beta; NF-κB: Nuclear factor-κB; TNF: Tumor necrosis factor; IL: Interleukin; STAT3: Signal transducer and active of transcription 3.
Figure 2 Hematoxylin-eosin (A, D) and immunostaining of claudin-1 (B, E) and β-catenin (C, F) in ulcerative colitis mucosa (A-C) and ulcerative colitis-associated colorectal cancer tissue (D-F) of a patient with ulcerative colitis-associated colorectal cancer.
- Citation: Kinugasa T, Akagi Y. Status of colitis-associated cancer in ulcerative colitis. World J Gastrointest Oncol 2016; 8(4): 351-357
- URL: https://www.wjgnet.com/1948-5204/full/v8/i4/351.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v8.i4.351